AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial

The combination of AstraZeneca's cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer showed positive results in a late-stage trial, the company said on Wednesday.